We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04547140
Brief Title: Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)

First Submitted : September 10, 2020
First Submitted that Met QC Criteria : September 10, 2020
First Posted : September 14, 2020

Last Update Submitted that Met QC Criteria : April 12, 2022
Last Update Posted : April 19, 2022